Speaker(s): 

Samuel Gidding, MD; Staff Member, Geisinger - has nothing to disclose.

Moderator(s): 

Dyan Cawley, Geisinger - has nothing to disclose. 

Learning Objectives: 

At the conclusion of this session, the participant should be able to: 

• define indications for FH screening
• evaluate patients to lipid specialists appropriately
• order genetic testing for FH when indicated
• utilize electronic health record resources effectively to facilitate aspects of FH care and management

Disclosure of Relevant Financial Relationships with/without Commercial Interests:

The Planning Committee consisting of Caroline deRichemond, CRNP, Activity Director, Samuel Gidding, MD, David Rolston, MD, Marie Kobylinski, MD, Matthew Nelson, DO, Shuping Ge, MD, Elizabeth Bordy, PA-C, Timothy Shuey, DO and Tyler Schubert have no identified disclosures. 

CE Committee Member/Content Reviewers have nothing to disclose.  

Any/All relevant financial relationships have been mitigated. 

Content Disclosure: 

This presentation/content is HIPPA compliant. 

Commerical Support for this Session

None.